Wraps Save Sweetgreen? Can a Menu Pivot Help the Stock?
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
Which Is Safer Multi Asset Retirement Fund Vs Sp 500
This intro discusses relative safety between Which Is Safer Multi Asset Retirement Fund Vs SP500 and the implications for retirees.
26,336 articlesBanks Bigger Role in Mortgages Amid Regulators Review
Regulators are examining capital rules that could allow banks to take a bigger share of mortgage lending. Banks say c...
Cognex (CGNX) 2026 Earnings Outlook: A Deep Dive Today
Cognex is navigating a world of AI-powered machine vision in manufacturing. This article breaks down the Q1 2026 resu...
Poet Technologies Stock Sold: Is It Time to Buy Now?
Poet Technologies stock sold off again as investors weigh dilution, growth prospects, and market jitters. This analys...
Calumet (CLMT) 2026 Earnings Outlook: A Deep Dive
This article breaks down calumet (clmt) 2026 earnings into actionable insights. Learn how to read the Q1 transcript, ...
Current Price June 2026: Oil Holds Near $95 a Barrel
Oil hovered around $95 per barrel on June 11, 2026, as traders weigh supply discipline and demand trends. The move co...
Why Is Microsoft Stock Falling, and Is It a Generational Buy?
Microsoft stock has pulled back in a surprising turn for a tech giant. This article unpacks the reasons behind the dr...
Why Ataibeckley Stock Soared Today After Lilly Deal
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Technology (Maps) 2025 Earnings: WM MAPS Outlook Guidance
WM Technology MAPS is weighing a pivotal year. This guide breaks down the Q4 2025 earnings, what technology (maps) 20...
Jumia (JMIA) 2026 Earnings: Q1 Signals for Investors
Jumia's Q1 2026 earnings call offers a clear view of how the company plans to scale across Africa. This article break...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status